Use of dabigatran vs. warfarin with low-molecular-weight heparin bridging in catheter ablation for atrial fibrillation patients with a low CHADS2 score

Biomedical Reports
Li HaoJing-Quan Zhong

Abstract

The purpose of the present study was to compare the efficacy and safety of dabigatran and interrupted warfarin with low-molecular-weight heparin bridging in non-valvular atrial fibrillation (AF) catheter ablation. Previously, there has been concerns that bridging therapy increases bleeding events without the benefit of stroke prevention. It has been suggested that bridging therapy should be considered only for patients at high-risk of thrombosis. Nevertheless, bridging therapy in AF patients with a low CHADS2 score may be safe and effective. The authors performed a prospective, observational study that included consecutive 240 patients undergoing AF ablation in P.R. China. A total of 139 patients received 110 mg dabigatran twice daily and 101 patients took dose-adjusted warfarin that had been bridged with low-molecular-weight heparin. The mean patient age was 55.48 years with 72.1% being men and 74.2% having paroxysmal AF. One thromboembolic complication occurred in the dabigatran group compared to none in the warfarin group. Both the groups presented a similar major bleeding rate, total bleeding rate, and bleeding and thromboembolic complications. In patients undergoing AF ablation, the risk of bleeding or thromboembolic compl...Continue Reading

References

Jun 13, 2001·JAMA : the Journal of the American Medical Association·B F GageM J Radford
Dec 9, 2009·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Ayman A HusseinOussama Wazni
Dec 10, 2009·Circulation. Arrhythmia and Electrophysiology·Riccardo CappatoElia Biganzoli
Feb 6, 2013·International Journal of Cardiology·Jocasta BallSimon Stewart
May 31, 2013·The New England Journal of Medicine·Todd H BaronRobert D McBane
Jun 8, 2013·Stroke; a Journal of Cerebral Circulation·Masatsugu HoriUNKNOWN RE-LY Investigators
Nov 15, 2013·British Journal of Haematology·Jignesh P Patel, Roopen Arya
Dec 19, 2013·Circulation·Alvaro Alonso, Lindsay G S Bengtson
Feb 20, 2014·JAMA : the Journal of the American Medical Association·Carlos A MorilloUNKNOWN RAAFT-2 Investigators
Mar 13, 2014·Nature Reviews. Cardiology·Ian SabirA John Camm
May 7, 2014·Pacing and Clinical Electrophysiology : PACE·Aysha ArshadJonathan S Steinberg
Nov 20, 2014·Stroke; a Journal of Cerebral Circulation·John W Eikelboom, Robert G Hart
Dec 3, 2014·Anaesthesia·J J van Veen, M Makris
Dec 17, 2014·Circulation·Benjamin A SteinbergUNKNOWN Outcomes Registry for Better Informed Treatment of Atrial Fibrillation Investigators and Patients
Apr 22, 2015·International Journal of Cardiology·Kevin PhanStuart P Thomas
Jun 23, 2015·The New England Journal of Medicine·James D DouketisUNKNOWN BRIDGE Investigators

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Related Papers

Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology
Aref A Bin AbdulhakAlan P Wimmer
Circulation Journal : Official Journal of the Japanese Circulation Society
Kenichi KasenoHiroshi Tada
© 2022 Meta ULC. All rights reserved